Current role
Biotechnology · Healthcare
CEO, Board Member
2024-11-27–present
Sandesh Seth
Equibles does not estimate personal net worth.
Get an email with a short summary when Actinium Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATNM alertsAbout Sandesh Seth
Sandesh Seth is recorded as Board Member at Actinium Pharmaceuticals, Inc. (ATNM) since November 27, 2024 and CEO at Actinium Pharmaceuticals, Inc. (ATNM). The newest filing on record that lists Sandesh Seth as CEO at Actinium Pharmaceuticals, Inc. (ATNM) is dated October 16, 2026. Actinium Pharmaceuticals, Inc. reported in an 8-K filed November 27, 2024 that Sandesh Seth was appointed Class II director, effective November 27, 2024. The proxy statement of Actinium Pharmaceuticals, Inc. reports total compensation of $1,187,320 for Sandesh Seth in fiscal 2025, including a base salary of $762,320. Disclosed compensation is on record for 8 fiscal years. Actinium Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actinium Pharmaceuticals, Inc. includes Matt David (CFO), Matt David, M.D. (CFO), Ajit S. Shetty (Board Member) and 5 others.
“At the Annual Meeting, each of Sandesh Seth and Jeffrey W. Chell was elected as a Class II director of the Board to serve for a term expiring at the Company’s 2027 annual meeting of stockholders.”
Affiliation history
-
Current
2024-11-27–present
-
Current
Start not stated–present
Last confirmed October 16, 2026
Company network
Leadership on record at Actinium Pharmaceuticals, Inc.
- Matt David CFO
- Matt David, M.D. CFO
- Ajit S. Shetty Board Member
- David Nicholson Board Member
- Jeffrey W. Chell Board Member
- June Almenoff, M.D., Ph.D. Board Member
- June S. Almenoff Board Member
- Richard I. Steinhart Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $762,320 | $1,187,320 |
| 2024 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $733,200 | $1,173,200 |
| 2023 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $705,000 | $4,704,999 |
| 2022 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $665,000 | $4,020,167 |
| 2021 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $615,000 | $2,335,323 |
| 2020 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $578,191 | $1,831,728 |
| 2019 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $561,350 | $1,102,717 |
| 2018 | Actinium Pharmaceuticals, Inc. (ATNM) | Chairman and Chief Executive Officer | $545,000 | $1,374,253 |